Indian pharmaceutical manufacturer FDC Ltd has initiated a voluntary recall of more than 60,000 bottles of its Timolol Maleate Ophthalmic Solution in the United States, following a manufacturing defect identified by the U.S. Food and Drug Administration (USFDA). The issue pertains to a faulty container mechanism that prevents proper drug dispensing. Classified as a Class II recall, the defect is considered unlikely to cause serious health risks but may result in temporary or reversible side effects.